SPOTLIGHT -
Dr. Lazarides on Research Regarding Margin Assessment in Sarcoma
Alexander Leandros Lazarides, MD, discusses research regarding margin assessment in patients with sarcoma.
Read More
Dr. Lazarides on CRM1 as a Potential Target in Osteosarcoma
Alexander Leandros Lazarides, MD, resident at Duke University Medical Center, discusses CRM1 as a potential target in osteosarcoma.
Dr. Lazarides on Challenges in Moving the Field of Osteosarcoma Forward
Alexander Leandros Lazarides, MD, discusses some of the current challenges in moving the field forward in osteosarcoma.
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
Currently Available Treatment Options for Patients With R/R DLBCL
Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
